Microbot Medical rises on plans to commence trial on robotic system
02/09/2022 18:09
** Shares of medical device maker Microbot Medical MBOT.O
rise up as much as 4.7% to $5.15
** MBOT says it is on track to begin a pre-clinical trial
for its Liberty robotic system devices later this month
urn:newsml:reuters.com:*:nGNX73Gp0C
** Co says it has recently shipped the devices to a research
laboratory for the trials
** Liberty is the first ever fully disposable surgical robot
designed to streamline endovascular procedures, according to the
co's website
** More than 8 thousand shares change hands, 1.1 times the
stock's 25-day moving average volume
** Stock is flat YTD
(Reporting by Nandhini Srinivasan in Bengaluru)
((Nandhini.Srinivasan@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones